Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,792 companies covered Latest filing Oct 6 History loaded for 0 of 4,792

  • $1.4B bought by 293 insiders at 194 companies
  • $6.3B sold by 282 insiders outside a trading plan
  • $3.3B sold by 627 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past month · by insider, all their filings added up

  1. LENLennar Corporation
    Berkshire Hathaway Inc.10% owner · +1 joint filer
    7,502,276 shares at $79.35 Sep 17–Oct 2 · 4 filings 3 superinvestors bought in Q2
    $595M
  2. KODKodiak Sciences Inc
    Baker Bros. Advisors LPDirector · +5 joint filers
    1,941,755 shares at $80.85 Sep 28–29 · 3 filings +11% to stake 1 superinvestor sold in Q2
    $157M
  3. CRBGCorebridge Financial Inc.
    Life Insurance Co Nippon10% owner
    3,623,743 shares at $34.22 Sep 16–Oct 2 · 13 filings +2.9% to stake 2 superinvestors bought in Q2
    $124M
  4. GPIGroup 1 Automotive, Inc.
    Conifer Management, L.L.C.10% owner
    465,650 shares at $246.24 Sep 17–30 · 3 filings +32% to stake 2 superinvestors bought in Q2
    $115M
  5. UUUUniversal Safety Products, Inc.
    Milton C Ault IIIDirector
    33,734 shares at $2,741.80 Sep 17–30 · 4 filings
    $92.5M
  6. GMEGameStop Corporation
    Ryan CohenCEO
    2,300,680 shares at $23.49 Sep 21–Oct 2 · 3 filings +5.8% to stake
    $54M
  7. GRABGrab Holdings Limited
    Anthony Ping Yeow TanCEO
    10.4M shares at $2.89 Sep 21 +2415% to stake
    $29.9M
  8. GSATGlobalstar, Inc.
    James Monroe IIIDirector
    361,600 shares at $82.52 Sep 18 +775% to stake
    $29.8M
  9. COURCoursera, Inc.
    Pale Fire Capital SE10% owner · +4 joint filers
    2,332,742 shares at $4.87 Sep 25–29 +8.8% to stake
    $11.4M
  10. CVCapsoVision, Inc.
    Eliyahou Et Al Harari10% owner
    1,757,469 shares at $5.69 Sep 18 New stake
    $10M

Biggest sales

Past month · by insider, all their filings added up · planned sales marked

  1. FANGDiamondback Energy, Inc.
    SGF FANG Holdings, LP10% owner · +1 joint filer
    18.2M shares at $205.26 Sep 16 · 2 filings 22% of stake
    $3.7B
  2. IHTInnSuites Hospitality Trust
    Marc E BergEVP & Secretary/Treasurer
    16,000 shares at $22,593.60 Sep 17 33% of stake Planned sale (10b5-1)
    $361M
  3. NVDANvidia Corporation Com
    Mark A StevensDirector
    1,366,000 shares at $219.73 Sep 18 59% of stake
    $300M
  4. AVGOBroadcom Inc.
    Henry SamueliDirector
    702,190 shares at $356.04 Sep 23 1.9% of stake Planned sale (10b5-1)
    $250M
  5. UMCUnited Microelectronics Corporation
    Chitung LiuCFO
    1,600,000 shares at $143.00 Sep 16–17 38% of stake
    $229M
  6. THTarget Hospitality Corp.
    TDR Capital II Investments LP10% owner · +9 joint filers
    11M shares at $18.40 Oct 1 40% of stake
    $202M
  7. AURAurora Innovation, Inc.
    Uber Technologies, Inc10% owner
    29.4M shares at $6.21 Sep 15 16% of stake
    $182M
  8. ESTCElastic N.V.
    Steven SchuurmanDirector
    1,500,000 shares at $90.13 Oct 5 25% of stake
    $135M
  9. CRWDCrowdStrike Holdings, Inc.
    Burt W. PodbereCFO
    513,882 shares at $259.91 Sep 21–24 · 2 filings Part planned (10b5-1)
    $134M
  10. MEDPMedpace Holdings, Inc.
    August J. TroendleCEO
    201,669 shares at $624.08 Sep 15–30 · 6 filings 37% of stake
    $126M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days · most buyers first

  1. SPGSimon Property Group, Inc. 11 insiders · $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  2. FULH. B. Fuller Company 7 insiders · $621K

    Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more

    Latest buy Sep 30 1 superinvestor bought in Q2
  3. ATCHAtlasClear Holdings, Inc. 5 insiders · $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  4. RGCORGC Resources Inc. 5 insiders · $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  5. MPBMid Penn Bancorp 5 insiders · $25K

    Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  6. SBLKStar Bulk Carriers Corp. 4 insiders · $4.2M

    Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer

    Latest buy Sep 15 2 executives 1 superinvestor bought in Q2
  7. PRHIPresurance Holdings, Inc. 4 insiders · $200K

    Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO

    Latest buy Sep 30 2 executives
  8. ANIXAnixa Biosciences, Inc. 4 insiders · $181K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Sep 30 2 executives
  9. WVVIWillamette Valley Vineyards, Inc. 4 insiders · $52K

    Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President

    Latest buy Oct 5 2 executives
  10. AUBNAuburn National Bancorporation, Inc. 4 insiders · $5,441

    J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President

    Latest buy Sep 30 1 executive

All insider trades

Newest filings first · one row per filing · every open-market buy and sale

All Buys Sales
Everyone CEOs CFOs Executives Directors 10% owners
Any size $100K+ $1M+ $10M+
Hide planned sales
  1. Anthony Mathew Eisen Director
    XYZBlock, Inc.
    Planned sale
    $1.4M 18,000 shares at $75.51 1.4% of stake
    Traded Oct 2–6 Filed Oct 6
    ↗
  2. Barry J. Simon Director
    IBRXImmunityBio, Inc.
    Planned sale
    $269K 25,000 shares at $10.75 0.9% of stake
    Traded Oct 5 Filed Oct 6
    ↗
  3. Cheryl Cohen Director
    IBRXImmunityBio, Inc.
    Planned sale
    $851K 81,056 shares at $10.50 45% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  4. Raanan Zilberman Director
    VSHVishay Intertechnology, Inc.
    Planned sale
    $594K 16,575 shares at $35.82 34% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  5. Corinna Lathan Director
    PTCPTC Inc.
    Planned sale
    $343K 1,750 shares at $195.75 21% of stake
    Traded Oct 5 Filed Oct 6
    ↗
  6. Eugene A Scherbakov Director
    IPGPIPG Photonics Corporation
    Planned sale
    $260K 3,048 shares at $85.30 6.3% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  7. Douglas A Alexander Director
    AMKRAmkor Technology, Inc.
    Planned sale
    $275K 5,000 shares at $55.00 15% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  8. Steven Schuurman Director
    ESTCElastic N.V.
    Sale
    $135M 1,500,000 shares at $90.13 25% of stake
    Traded Oct 5 Filed Oct 6
    ↗
  9. Carrie Palin Director
    NTAPNetApp, Inc.
    Sale
    $1.1M 5,000 shares at $216.43 43% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  10. Michael J Kasbar Chair
    WKCWorld Kinect Corporation
    Planned sale
    $357K 10,000 shares at $35.67 1% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  11. Amar K. Goel Chair
    PUBMPubMatic, Inc.
    Planned sale
    $201K 10,795 shares at $18.66 23% of stake
    Traded Oct 5 Filed Oct 6
    ↗
  12. Stanley Tang Director
    DASHDoorDash, Inc.
    Planned sale
    $4.3M 23,125 shares at $186.19 69% of stake
    Traded Oct 2 Filed Oct 6
    ↗
  13. Gerald Held Director
    NTAPNetApp, Inc.
    Sale
    $1.2M 5,757 shares at $212.00 36% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  14. Lauren Elaina Friedman Stat Director
    PLTRPalantir Technologies Inc.
    Planned sale
    $254K 1,337 shares at $189.95 2.5% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  15. Sameer K Gandhi Director
    CRWDCrowdStrike Holdings, Inc.
    Planned sale
    $14.3M 54,000 shares at $265.22 1.9% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  16. Mark B Templeton Director
    ANETArista Networks, Inc.
    Planned sale
    $1M 5,000 shares at $204.37 9.4% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  17. Timothy D Cook Chair
    AAPLApple Inc Com
    Planned sale
    $63.8M 191,753 shares at $332.96 5.5% of stake
    Traded Oct 2 Filed Oct 5
    ↗
  18. Daniel Masters Director
    CSHRCoinShares PLC
    Planned sale
    $492K 100,000 shares at $4.92 0.5% of stake
    Traded Oct 1–5 Filed Oct 5
    ↗
  19. Neil D Hunt Director
    ROKURoku, Inc.
    Planned sale
    $302K 2,000 shares at $151.09 17% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  20. Melissa B Epperly Director
    ROIVRoivant Sciences Ltd.
    Planned sale
    $641K 17,750 shares at $36.10 54% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  21. Jeffrey W Dunn Director
    SIBNSI-BONE, Inc.
    Planned sale
    $369K 20,000 shares at $18.47 56% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  22. Christopher M Starr Director
    MNPRMonopar Therapeutics Inc.
    Planned sale
    $659K 8,400 shares at $78.50 62% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  23. Marc L Andreessen Director
    COINCoinbase Global, Inc.
    Planned sale
    $3.9M 20,514 shares at $190.12 1.8% of stake
    Traded Oct 1–2 Filed Oct 5
    ↗
  24. John Philip Coghlan Director
    LIFLife360, Inc.
    Planned sale
    $161K 4,000 shares at $40.37 24% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  25. Vincentelli Alberto Sangiovanni Director
    CDNSCadence Design Systems, Inc.
    Planned sale
    $438K 1,250 shares at $350.07 3.1% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  26. Frederic Simon Director
    FROGJFrog Ltd.
    Planned sale
    $11.7M 120,000 shares at $97.24 4.2% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  27. J. Scott Garland Director
    ELVNEnliven Therapeutics, Inc.
    Sale
    $607K 13,000 shares at $46.67 100% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  28. Josh Silverman Chair
    ETSYEtsy
    Planned sale
    $151K 2,090 shares at $72.45 0.8% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  29. Bruce C Cozadd Director
    JAZZJazz Pharmaceuticals plc
    Planned sale
    $1.4M 6,000 shares at $230.33 1.7% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  30. Andy Fang Director
    DASHDoorDash, Inc.
    Planned sale
    $918K 5,000 shares at $183.69 100% of stake
    Traded Oct 1 Filed Oct 5
    ↗
  31. George Raymond Zage III Director
    GRNDGrindr Inc.
    Planned sale
    $6.9M 500,000 shares at $13.87 6.6% of stake
    Traded Oct 1–2 Filed Oct 5
    ↗
  32. Tomas Braun Director
    GGALGrupo Financiero Galicia S.A.
    Sale
    $188K 39,562 shares at $4.75 13% of stake
    Traded Mar 20–Sep 14 Filed Oct 5
    ↗
  33. Charles Kissner Director
    RMBSRambus, Inc.
    Planned sale
    $555K 5,000 shares at $111.00 57% of stake
    Traded Oct 2 Filed Oct 5
    ↗
  34. Michael L Speiser Director
    SNOWSnowflake Inc.
    Planned sale
    $17.5M 50,741 shares at $344.00
    Traded Oct 2 Filed Oct 2
    ↗
  35. Joseph F Hanna Director
    MGRCMcGrath RentCorp
    Planned sale
    $863K 7,500 shares at $115.04 4.9% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  36. Foundation Fighting Blindness Retinal Degeneration Fund Director · +1 joint filer
    IRDOpus Genetics, Inc.
    Sale
    $2.8M 556,000 shares at $4.96 15% of stake
    Traded Sep 30 Filed Oct 2
    ↗
  37. Randolph Altschuler Director
    XMTRXometry, Inc.
    Planned sale
    $1M 10,000 shares at $104.04 1.8% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  38. Ita M Brennan Director
    PLPlanet Labs PBC
    Planned sale
    $187K 11,500 shares at $16.30 4.4% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  39. Gregory Baszucki Director
    RBLXRoblox Corporation
    Planned sale
    $714K 16,666 shares at $42.87 1.3% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  40. John Wendell Thompson Director
    RBRKRubrik, Inc.
    Planned sale
    $1.6M 13,500 shares at $115.69
    Traded Oct 1 Filed Oct 2
    ↗
  41. Hollings Renton Director
    ANABAnaptysBio, Inc.
    Planned sale
    $249K 5,000 shares at $49.87 31% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  42. Glenn Steele Jr. MD PHD Director
    PTCTPTC Therapeutics, Inc.
    Planned sale
    $782K 12,000 shares at $65.16 35% of stake
    Traded Sep 30 Filed Oct 2
    ↗
  43. Jeffrey Jacob Raider Director
    WRBYWarby Parker Inc.
    Planned sale
    $416K 15,000 shares at $27.70 3.4% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  44. Matthew L. Posard Director
    HALOHalozyme Therapeutics, Inc.
    Planned sale
    $568K 5,230 shares at $108.54 8.9% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  45. Daniel Freifeld Director
    MRTMarti Technologies, Inc.
    Sale
    $2.6M 1,350,000 shares at $1.91 18% of stake
    Traded May 18–Sep 9 Filed Oct 2
    ↗
  46. Paul Cahill Sciarra Director
    JOBYJoby Aviation, Inc.
    Planned sale
    $381K 62,500 shares at $6.09 0.1% of stake
    Traded Oct 2 Filed Oct 2
    ↗
  47. Ulrike Helfer Director
    GSLGlobal Ship Lease, Inc.
    Sale
    $179K 4,000 shares at $44.82 32% of stake
    Traded Sep 30 Filed Oct 2
    ↗
  48. Jennifer Tejada Chair
    PDPagerDuty, Inc.
    Planned sale
    $1.6M 107,000 shares at $15.11 6.4% of stake
    Traded Sep 30 Filed Oct 2
    ↗
  49. William S. Creekmuir Director
    FLXSFlexsteel Industries, Inc.
    Sale
    $101K 1,250 shares at $81.13 6.2% of stake
    Traded Sep 14–15 Filed Oct 2
    ↗
  50. May Yihong Wu Director
    NOAHNoah Holdings Ltd.
    Sale
    $126K 16,000 shares at $7.89 44% of stake
    Traded Sep 29–30 Filed Oct 2
    ↗

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.